I’ve been buying $Tempus AI(TEM)$ in the $40 range I think this stock can do some big gains based on AI growing at a rapid pace and this specifically being in the healthcare field plus they are receiving government grants and the best trader on the planet Nancy Pelosi is in.

💰 In the world of short-term investing, stories, news, and unexpected events are the secrets of investing.💹 Event-driven markets usually last for a few days or less. As long as you are not the last one to get on the train, you will not lose money, but this requires the ability to resist greed.📣 Stay tuned and supercharge purchasing power with CashBoost!IntroductionAs the penetration rate of AI in the industry continues to increase, more and more industries have announced the use of AI to empower their own businesses, such as AI Powered Healthcare, AI Powered Education, etc.Last week, on February 13, President Trump signed an executive order to establish the "MAHA" (Make America Healthy Again) committee. Although Trump is known for his "around-the-clock" governance style, with his "Twitter-

Traders May Finally get the chance to BUY $Tempus AI(TEM)$ at same cost level as Nancy Pelosi likely today

AI is the way forward 

Hims & Hers Stock Is On Fire. Is It a Meme? $Hims & Hers Health Inc.(HIMS)$ has been in the Asymmetric Universe since May 24, 2024, when this Spotlight article was published. I thought the company had 10x potential over the next decade, disrupting how we think about getting medicine in an internet world.What I didn’t expect was for shares to be up 258.2% in just under 9 months and 142.1% this year alone.Has the stock become a meme? Is buying now crazy? Or is the rocket ship just taking off?Hims & Hers Growth Is Out of This WorldSince 2018, Hims & Hers has grown revenue at a 95% compound annual growth rate and expects to grow revenue 90% this quarter. There aren’t many companies growing that fast and improving profitability at the s

$Tempus AI(TEM)$ TEM’s AI-driven health solutions are driving strong revenue growth, backed by rising demand for precision medicine and diagnostics. Its expanding market share and improving margins reinforce confidence in future profitability. With continued innovation and strategic partnerships, earnings should support high estimates, keeping investor sentiment bullish.

Palantir (PLTR) and Hims & Hers Health (HIMS) operate in completely different sectors—Palantir in AI-driven data analytics for government and enterprises, and Hims in telehealth and direct-to-consumer healthcare. Here's why PLTR might be considered the better stock:   ### **1. Strong Competitive Moat**   - **Palantir** has deep government contracts (U.S. DoD, CIA, etc.), providing a steady revenue base.   - **Hims** faces competition from numerous telehealth providers (Amazon, Ro, etc.), limiting pricing power.   ### **2. Scalability & Growth Potential**   - **PLTR** benefits from AI and big data trends, expanding its commercial segment alongside its dominant government business.   - **Hims** is a niche player in telehealt

You can build an incredible portfolio picking a few of these 20 stocks: AI Hardware |$ASML Holding NV(ASML)$ $Taiwan Semiconductor Manufacturing(TSM)$ $NVIDIA(NVDA)$ Hyperscalers | $Amazon.com(AMZN)$ $Microsoft(MSFT)$ $Alphabet(GOOG)$ Fintech | $Nu Holdings Ltd.(NU)$ $SoFi Technologies Inc.(SOFI)$ $DLocal Limited(DLO)$ Healthcare | $Hims & Hers Health Inc.(HIMS)$

$Tempus AI(TEM)$ TEM's earnings outlook remains robust, supporting high estimates, especially within the AI + health sector. Here’s why:1. AI Integration in Healthcare: TEM’s focus on integrating AI into healthcare solutions positions it well for growth. As AI continues to revolutionize diagnostics, treatment recommendations, and patient management, TEM stands to benefit from expanding market opportunities, especially in telemedicine and AI-driven medical tools.2. Strong Earnings Growth: TEM has shown consistent earnings growth, with solid performance in both AI and healthcare segments. This foundation gives confidence that the company can meet or exceed analyst estimates. The scalability of their AI-powered solutions also

Palantir (PLTR) and Hims & Hers Health (HIMS) operate in completely different industries—one in data analytics and AI for government and enterprises, the other in telehealth and consumer wellness. However, comparing their fundamentals reveals interesting insights into growth, profitability, and market positioning.For example: Revenue Growth: Both companies have seen strong revenue growth, but Palantir’s government contracts provide stability, while Hims relies on a subscription-based DTC (direct-to-consumer) model. Profitability: Palantir has achieved GAAP profitability, whereas Hims is still working toward it. Valuation: PLTR trades at a higher multiple due to its AI-driven hype, while HIMS is valued more as a high-growth healthcare play. $Hims &

12 stocks that will give you exposure to each major secular growth theme for the next decade • $Amazon.com(AMZN)$ | Cloud Computing • $Meta Platforms, Inc.(META)$ | AR/VR • $NVIDIA(NVDA)$ | Generative AI • $Tesla Motors(TSLA)$ | Robotics & Automation • $Palantir Technologies Inc.(PLTR)$ | Big Data • $CrowdStrike Holdings, Inc.(CRWD)$ | Cybersecurity • $Tempus AI(TEM)$ | Healthcare AI • $NANO Nuclear Energy Inc(NNE)$ | Nuclear Energy •

Hello everyone! Today i want to share some trading ideas with you!1. $Hims & Hers Health Inc.(HIMS)$ is following the $Amazon.com(AMZN)$ playbook:More, cheaper, faster…It’s rapidly launching into new markets, offering cheaper prices and you can get your personalized treatment in days.This is a powerful growth engine. $Hims & Hers Health Inc.(HIMS)$ will be a $100 billion company.2. $MercadoLibre(MELI)$ and $Nu Holdings Ltd.(NU)$ both are still amazing opportunities. $MercadoLibre(MELI)$ still has 15 more countries to expand to in

$Tempus AI(TEM)$  🚨 Tempus AI (TEM) – Overhyped or the Next Big Thing? 🚨 🔥 Tempus AI is soaring at $91 (highest point), but is the hype justified? Here’s the REAL breakdown: 📉 Fundamentals Say SELL 🔹 P/S Ratio: 20.6x (Industry Avg: 8x) 🔹 EV/Revenue: 27.5x (More than double high-growth AI stocks) 🔹 Massive overvaluation compared to Palantir, Datadog & Recursion Pharma 📊 Fair Value Estimate: $32 Based on Q2 & Q3 2024 reports, the stock should trade between $20-$48 – meaning a 63% downside risk from current levels! 🚀 Hype or Reality? Yes, AI & Healthcare Data is the future, but can Tempus AI justify this valuation? If growth slows, a major correction is coming. 💡 What’s your take? Is TEM a Buy, Hold, or Sell?

$NEBIUS(NBIS)$   and $AppLovin Corporation(APP)$  Show Strong Uptrend with Rising RSI and Abnormal Volume Spikes!" ⚡ Breakout Alert! $Hims & Hers Health Inc.(HIMS)$  Surges with 360% Volume Increase, Trading Near 52-Week High! 🔥 Overbought or Still Running? "Multiple Stocks (HIMS, NBIS, APP) Have RSI Above 80 – Momentum or Reversal Ahead?" 📈 Market Movers: High Volume, High Returns! "NBIS Leads with 656% Volume Surge – Is the Rally Just Beginning?" ⚠️ Cooling Off? $Root, Inc.(ROOT)$ ’s Falling RSI Signals Possible Slowdown After Strong Uptrend!"

$TEM  This one has been great. Admitted....this is the first ticker I admit that I instantly bought as soon as PR came out about someone buying (Pelosi's husband). I would put any amount that he/she are not going to invest 'unless they know...with the inside scoop'. Now playing on house money so to speak. It will be interesting how much further it goes. While Pelosi's investment was notable...it was not what some would consider a 'huge amount'. Expecting a decent pull back at some point soon.